Stathmin: a protein with many tasks. New biomarker and potential target in cancer

By Belletti Barbara   Baldassarre Gustavo  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1249-1266

Informa Healthcare

Access to resources Recommend Favorite

FOXP1: a potential therapeutic target in cancer

By Koon Henry B   Ippolito Gregory C   Banham Alison H   Tucker Philip W  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 955-965

Informa Healthcare

Access to resources Recommend Favorite

Protein Geranylgeranyltransferase Type 1 as a Target in Cancer

By  

Current Cancer Drug Targets, Vol. 16, Iss. 7, 2016-08 ,pp. : 563-571

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A.   Ackland1 S.P.   Gardiner E.   Walkom C.C.   Sakoff1 J.A.  

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1744-1760

Bentham Science Publishers

Access to resources Recommend Favorite